AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For First Busey, the core investor belief is that a conservative, dividend-paying regional bank can keep turning solid profitability into disciplined capital returns, even as growth expectations remain modest and return on equity stays in single digits. The short term story still hinges on sustaining recent earnings improvement, managing credit quality after past charge offs, and balancing a growing buyback program with a rising common dividend. Mike Daley’s move into the chief strategy officer role fits into that picture as an internal evolution rather than a step change. It may fine tune how First Busey weighs growth against efficiency and capital deployment after the CrossFirst integration, but recent price moves and the existing thesis suggest the appointment is not, by itself, a material new catalyst or risk.
However, investors should keep a close eye on how capital returns interact with still-modest profitability. Despite retreating, First Busey's shares might still be trading 41% above their fair value. Discover the potential downside here.Explore 2 other fair value estimates on First Busey - why the stock might be worth as much as 70% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com